cGAS‐STING pathway agonists are promising vaccine adjuvants
Medicinal Research Reviews · 2024-07 · 44 (4) · 1768-1799
DOI: 10.1002/med.22016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 07.02.2024. Verfasst von Xinyu Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Centre for Geriatrics, West China…. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation for Excellent Young Scholars (32122052) and National Natural Science Foundation Regional Innovation and Development (No. U19A2003)..
Abstract (Originalsprache)
Adjuvants are of critical value in vaccine development as they act on enhancing immunogenicity of antigen and inducing long‐lasting immunity. However, there are only a few adjuvants that have been approved for clinical use, which highlights the need for exploring and developing new adjuvants to meet the growing demand for vaccination. Recently, emerging evidence demonstrates that the cGAS‐STING pathway orchestrates innate and adaptive immunity by generating type I interferon responses. Many cGAS‐STING pathway agonists have been developed and tested in preclinical research for the treatment of cancer or infectious diseases with promising results. As adjuvants, cGAS‐STING agonists have demonstrated their potential to activate robust defense immunity in various diseases, including COVID‐19 infection. This review summarized the current developments in the field of cGAS‐STING agonists with a special focus on the latest applications of cGAS‐STING agonists as adjuvants in vaccination. Potential challenges were also discussed in the hope of sparking future research interests to further the development of cGAS‐STING as vaccine adjuvants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
ORCID-Profile: Xiawei Wei
Förderung
- National Science Foundation for Excellent Young Scholars (32122052) and National Natural Science Foundation Regional Innovation and Development (No. U19A2003).
Zitieren
APA
Tian, X., Ai, J., Tian, X., & Wei, X. (2024). cGAS‐STING pathway agonists are promising vaccine adjuvants. Medicinal Research Reviews, 44(4), 1768-1799. https://doi.org/10.1002/med.22016
Vancouver
Tian X, Ai J, Tian X, Wei X. cGAS‐STING pathway agonists are promising vaccine adjuvants. Medicinal Research Reviews. 2024;44(4):1768-1799. doi:10.1002/med.22016
BibTeX
@article{Tian2024,
author = {Tian, Xinyu and Ai, Jiayuan and Tian, Xiaohe and Wei, Xiawei},
title = {cGAS‐STING pathway agonists are promising vaccine adjuvants},
journal = {Medicinal Research Reviews},
year = {2024},
volume = {44},
number = {4},
pages = {1768--1799},
doi = {10.1002/med.22016}
}
EUVIMED